Longitude raises $525m for third fund

Menlo Park-based venture capital firm Longitude Capital has closed on a new biotech and life sciences fund.

27 June 2016•2 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.

Fundraising Investors Managers North America Limited Partners Fundraising Investor Commitments